Dr Vivek Reddy (Icahn School of Medicine at Mount Sinai, New York, NY, US) joins us to discuss evolving strategies for stroke management following atrial fibrillation ablation, addressing the critical question of when anticoagulation can be safely discontinued after successful ablation.

Interview Questions:

1. There's been a lot of talk about optimal anticoagulation – what's the headline? In which patients can we discontinue medication after successful ablation?
2. What about in cases of silent AF recurrence, is there still a risk?
3. Where does this leave us – do you think concomitant LAAC with new technologies could be the answer?

Recorded on-site at AF Symposium 2026, Boston.
Editor: Jordan Rance
Videographer: David Ben-Harosh
Support: This is an independent interview produced by Radcliffe Cardiology.